---
title: "Belite Bio joins H.C. Wainwright ophthalmology virtual conference panel July 22"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292763511.md"
description: "Belite Bio Inc. will participate in a panel discussion at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026."
datetime: "2026-07-15T12:03:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292763511.md)
  - [en](https://longbridge.com/en/news/292763511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292763511.md)
generator: "portal-rs"
---

# Belite Bio joins H.C. Wainwright ophthalmology virtual conference panel July 22

-   Belite Bio scheduled to join a panel at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150800PRIMZONEFULLFEED9762540) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BLTE.US](https://longbridge.com/en/quote/BLTE.US.md)

## Related News & Research

- [Belite Bio to present Phase 3 DRAGON tinlarebant results in Stargardt disease at SOG congress](https://longbridge.com/en/news/296615069.md)
- [Belite Bio to Host Virtual Commercial Day on September 2, 2026 | BLTE Stock News](https://longbridge.com/en/news/296824258.md)
- [You don't have to be a stock picker to make money in the market, expert says](https://longbridge.com/en/news/296416090.md)
- [Bausch + Lomb Advancing Two First-In-Class Eye Health Therapies Based On Trial Results](https://longbridge.com/en/news/296827543.md)
- [Harrow’s Iheezo Cuts Eye-Injection Discomfort by More Than Half](https://longbridge.com/en/news/296638124.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**